Artrya Share Price and Company Fundamentals



Price
$1.16
Change
0.010 (0.870%)
52 week
1.07 - 1.75

Last traded: Today at 1:22 AM

Artrya Limited operates as a medical technology company that uses artificial intelligence (AI) powered image-analysis software to enhance the detection and management of coronary artery disease. It offers Salix, a cloud-based software that uses its proprietary AI algorithms to interpret data from coronary computed tomography angiography scans and delivers findings in a single point of care solution. The company's Salix suite comprises Salix Coronary Anatomy and Salix Coronary Flow. It serves radiologists and cardiologists worldwide. The company was founded in 2018 and is based in Crawley, Australia.

Key Metrics

PE ratio

-

PB ratio

-

Dividend yield

Beta

-

Market cap

-

Enterprise value

-

Company profile

Primary activitiesArtrya Limited is a medical technology company developing software which automates the analysis of heart computed tomography (CT) scans to assist in the diagnosis of Coronary Artery Disease.
Industry / SectorHealth Information Services / Healthcare
Websitehttps://www.artrya.com
Mailing addressSuite 14A Level 3 88 Broadway Crawley WA 6009 Australia
Phone / Fax61 8 6478 7816 /
Share registryCOMPUTERSHARE INVESTOR SERVICES PTY LIMITED

Dividends

Artrya does not pay dividends.

Company Executives

As of Jan 2022, following are the company executives and directors listed on Artrya.

NameTitleAgeTotal Pay
Mr. John Windsor Barrington A.M.Co-founder, MD & Director
Mr. Mark WainwrightChief Financial Officer
Dr. Julien FlackChief Technology Officer
Ms. Jessica MonkChief Marketing Officer
Ms. Janice MarconChief People & Culture Officer
Mr. John Konstantopoulos B.E.Exec. Director of Product & Director
Prof. Girish DwivediChief Medical Officer
Mr. Nathan BartropCompany Sec.

Profitability and management effectiveness

Profit margin

0.00%

Operating margin

0.00%

Return on assets

-28.41%

Return on equity

-49.76%

Profitability ratios are a class of financial metrics that are used to assess a business's ability to generate earnings relative to its revenue, operating costs, balance sheet assets, and shareholders' equity over time, using data from a specific point in time.

The return on equity signifies how well the management is running the company in terms of capital management. The ideal return on equity is greater than 10%. The return on equity is calculated as net income divided by total share holders equity.

Valuation and Trading Info

The market capitalization of Artrya is and its enterprise value is .

Companies similar to Artrya (AYA)

Artrya (ASX:AYA) Frequently Asked Questions

1. What is Artrya's Stock Symbol?

Artrya trades on ASX under the ticker symbol "AYA".

2. What is Artrya's stock price today?

One share of AYA stock can currently be purchased for approximately $1.16.

3. How can I contact Artrya?

Artrya's mailing address is Suite 14A Level 3 88 Broadway Crawley WA 6009 Australia. The company can be reached via phone at 61 8 6478 7816.

4. What is Artrya's official website?

The official website of Artrya is https://www.artrya.com.

5. Which share registry manages Artrya's stock?

Artrya's stock is managed by COMPUTERSHARE INVESTOR SERVICES PTY LIMITED.